Alendronate comment watch save
BreastfeedingPediatric

  • TRADE NAMES: Alendronic acid; Binosto (Mission); Fosalan; Fosamax (Merck)
  • INDICATIONS: Osteoporosis in postmenopausal women, Paget’s disease
  • CLASS: Bisphosphonate
  • HALF-LIFE: >10 years
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Please login to view the rest of this drug profile.

Page last updated 05/05/2025

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top